Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.
Our portfolio company MGB BioPharma, a biopharmaceutical company who is developing a novel class of anti-infectives, to address the major global problem of antibiotic resistance, has today announced that the Food and Drug Administration (FDA) and Health Canada have cleared Investigational New Drug applications (IND/CTA) for its lead candidate. MGB-BP-3 is a novel antibiotic that targets Clostridium difficile-Associated Diarrhoea (CDAD). The […]
Another Record Year of Investment for Archangels 2018 has been another highly active year for Archangels, we have led a record breaking £22.4m of investment in Scottish tech and life sciences businesses. Including £10.9m of our members’ cash in 10 investment rounds across the year, with co-investment of £9.4m from investment partners including Scottish Enterprise’s […]
Investor of the Year Award Winner: Archangels On 29th November 2018, the team behind Scottish tech conference, Turing Fest, held the first ever Scottish Tech Startup Awards to recognise the people and companies leading the way in building the country’s digital economy. The awards were presented at an end-of-year party, bringing together all those working […]
Leading cyber security software specialist, ZoneFox has been sold by its shareholders Leading cyber security software specialist, ZoneFox, has been sold by its shareholders – including Scottish business angel investment syndicates, Archangels and TriCap, Scottish Investment Bank and Napier University – to US-based Fortinet. ZoneFox was established in 2010 and focuses on providing world-class security […]
World-leading speech technology business sets sights on global customer service market following £2m investment. The team behind Lara Croft’s smile in the newly launched bestselling Shadow of the Tomb Raider video game are turning their technology sights on the customer service sector following a significant funding boost. Speech Graphics is an Edinburgh and California based […]
Optoscribe is set to increase its manufacturing capacity and engineering resource to meet significant customer demand. Optoscribe, a leading supplier of glass-based integrated photonics components, today announced that the company has closed an investment round of £2.8 million. This funding will facilitate an expansion of current manufacturing capacity, the hiring of key engineering […]
NetThings has developed an “internet of things” platform that connects devices to be monitored and controlled over the Internet.
ZoneFox is a highly scalable data protection software solution that can expand easily and quickly with an organisation’s requirements.
MGB Biopharma’s focus is on developing a completely new class of anti-infective medicine, starting with antibiotics which are based on Minor Groove Binder (MGBs) compounds.
Founded nearly two decades ago, today Indigo Lighthouse empowers brands to convert consumers into loyal subscribers with its plug-and-play outsourcing solution for Subscription Loyalty Programmes.
Reactec are pioneers in developing novel solutions for managing the risks faced by power tool users. Power tools emit vibrations which cause irreversible sensory damage limiting an individual’s quality of life and capability to perform manual skills.
NCTech design and manufacture leading 360 degree rapid imaging systems that streamline the workflow of image documentation and can be used repeatedly, accurately, consistently by anyone anywhere.
PowerPhotonic designs and manufactures precision micro-optics for the global laser industry. Their products are used in a wide range of applications, including industrial laser material processing, medical systems, optical communications and big science.
Arrayjet’s platform technology uses unique, non-contact, inkjet printing offering unrivalled speed, reproducibility and precision.
Calcivis is an innovative medical devices company focused on revolutionising the management of dental caries or ‘tooth decay’.
With an expertise in compact and innovative technology Trig provides aircraft owners with transponder and radio communications equipment that is smart, affordable and future proof.
Lux Assure provide revolutionary new technology to detect, measure and monitor chemical concentrations within the oil and gas industry. Lux methods are safe, fast and non-intrusive.
PhysioMedics™ Limited was established in 2010, to create clinical software which automates the management of muscle and joint (MSK) problems.
Critiqom offers a complete, cost effective one-stop outsourcing solution for personalised ‘business critical’ documents – from creation through the lifecycle of document printing, distribution, postal management and electronic archiving.
Administrate is an affordable, online training management solution that saves time and money.
Effective data analysis and interpretation is the bottleneck and pain point for all users of “big data” technologies and Fios Genomics is ideally positioned to exploit emerging opportunities.
Blackford Analysis is a provider of software products that are designed to be integrated directly into any image viewer and work seamlessly within existing systems, to accelerate comparison of medical images.
Cytomos aims to revolutionise cell analysis by moving key tests out of the laboratory. Cytomos’ proprietary and patentable technology, which is in early stage development, is low-cost, portable and scalable.
Bio-images Drug Delivery Ltd (BDD) is a drug delivery company specialising in the development of modified and controlled release oral formulations.
- Sarah Hardy, our Chief Investment Officer, is on the panel @scotent SIB #ScotlandIsNow event at @LSEplc this mornin… https://t.co/D9Ygopn6r2Archangel Investors Ltd about 20 days ago
- RT @Insidermag: Glasgow-based @MGB_Biopharma - which is developing treatment to address the global problem of antibiotic resistance - been…Archangel Investors Ltd about 24 days ago
- Congratulations to our portfolio company @MGB_Biopharma who have clearance for clinical trials from the FDA and Hea… https://t.co/SP7PIglzuvArchangel Investors Ltd about 24 days ago